Clinical

Articles

Thomas J. Eichler, MD, FASTRO, presented data during a media briefing from surveys of radiation oncologists treating patients with cancer through the COVID-19 pandemic.

ASTRO Survey of Radiation Oncologists Shows Treatment Delays, Health Disparities Resulting From COVID-19 Pandemic

Data published in The Lancet Oncology found that a hypofractionated radiation schedule of 55 Gy in 20 fractions is noninferior to a schedule of 64 Gy in 32 fractions for patients with this disease.

Lower-Dose Hypofractionated Radiotherapy Schedule Proves Effective for Patients With Locally Advanced Bladder Cancer

A recent trial investigating the potential for stereotactic ablative body radiotherapy to treat patients with extracranial oligometastatic cancer found improved survival and a manageable safety profile.

Stereotactic Ablative Body Radiotherapy Improved Survival, Maintained Safety for Oligometastatic Cancers

Data published in Cancer found adjuvant radiotherapy after distal cholangiocarcinoma resection was associated with a survival benefit for patients, regardless of margin or nodal status.

Adjuvant Radiotherapy Linked With Survival Benefit After Distal Cholangiocarcinoma Resection 

This study suggested that the racial composition of clinical trials involving radiation therapy does not match that of the overall US population. 

Racial Composition of Trials Involving RT Does Not Match Overall US Population

“Sexual dysfunction is an unfortunately common side effect of cancer treatment, and there appears to be a large gender disparity in how physicians discuss sexual health with their patients,” said lead study author James Taylor, MD, MPH.

Sexual Dysfunction Not Well Addressed in Female Cancer Survivors

Researchers found there has been a 17% growth in radiation therapy facilities over the last 15 years, with expansion specifically improving for those who already live near such facilities.

Access to Radiation Therapy Expands, Especially in Densely Populated Areas

Stereotactic body radiotherapy may be superior to conventional palliative radiotherapy in improving the complete response rate for pain related to spinal metastases at 3- and 6-months post-radiation.

SBRT Appears to be Superior to CRT for Controlling Pain Related to Spinal Metastases

When compared with whole brain radiation therapy, researchers discovered highly focused radiation therapy led to less cognitive decline while simultaneously delivering equivalent overall survival rates.

Study Suggests Stereotactic Radiosurgery Become Standard of Care for Patients with 4+ Brain Metastases

It may soon be possible to get rid of the “one-size-fits-all” approach when it comes to radiation therapy.  

Radiation Oncology | Topics